« Back to Record
Bachet, J.-B., Marechal, R., Demetter, P., Bonnetain, F., Cros, J., Svrcek, M., Bardier-Dupas, A., Hammel, P., Sauvanet, A., Louvet, C., Paye, F., Vaillant, J.-C., André, T., Closset, J., Salmon, I., Emile, J.-F., & Van Laethem, J.-L. (2013). S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma. European journal of cancer, 49(12), 2643-2653. doi:10.1016/j.ejca.2013.04.017
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/148894



